What the Science Says About Sauna for Longevity: Infrared vs. Traditional

What the Science Says About Sauna for Longevity: Infrared vs. Traditional

Sauna is everywhere in the longevity conversation, but are all saunas actually doing the same thing? In this episode, Dr. Kara Fitzgerald sits down with Sunlighten co-founder Connie Zack to unpack the science of infrared sauna vs. traditional Finnish sauna, how different wavelengths of infrared and red light interact with the body, and what the research suggests about cardiovascular health, mitochondrial function, recovery, metabolism, and healthy aging. They explore the important distinction between heat therapy and light therapy, including far-, mid-, and near-infrared wavelengths and red light, why wavelength, dose, and proximity matter, and how these modalities may be used together. They also discuss practical sauna protocols, including how long and how often to use infrared sauna, and why hotter isn’t necessarily better.

What Actually Slows Aging? The Science vs. Hype | Dr. David Barzilai

What Actually Slows Aging? The Science vs. Hype | Dr. David Barzilai

In this episode of New Frontiers, Dr. Kara Fitzgerald sits down with longevity physician Dr. David Barzilai to separate promising science from hype and explore where the field of longevity medicine is headed. They discuss the evolution of biological age testing, including DunedinPACE and other aging clocks, and why these tools can provide useful information without telling the whole story. They also explore how AI and emerging technologies could transform personalized medicine, helping clinicians better identify which interventions may actually benefit an individual.

What New Science Reveals About Mitochondria & How We Age | Dr. Siobhan Mitchell

What New Science Reveals About Mitochondria & How We Age | Dr. Siobhan Mitchell

In this episode of New Frontiers in Functional Medicine, Dr. Kara Fitzgerald sits down with neuroscientist and mitochondrial health researcher Dr. Siobhan Mitchell to explore emerging research on mitochondrial dysfunction, aging, and longevity. They discuss how mitochondria change as we age, how mitochondrial dysfunction may contribute to chronic inflammation and age-related disease, and why supporting mitochondrial health could be an important strategy for extending healthspan.

The GLP-1 Problem No One Is Talking About: A New Metabolic Approach

The GLP-1 Problem No One Is Talking About: A New Metabolic Approach

GLP-1 receptor agonists have transformed the way we approach obesity and metabolic disease. The results can be remarkable. But as their use continues to expand, I think we need to be asking a bigger question: what does long-term metabolic health look like beyond weight loss? In this episode of New Frontiers, I sit down with Dr. Sanjay Bhojraj and Dr. Alexis Gonzales to explore a completely different way of thinking about metabolic intervention. Rather than systemically suppressing appetite or altering hormonal signaling, we look upstream at digestion itself, specifically whether changing the rate at which carbohydrates and fats are broken down can meaningfully alter postprandial glucose, visceral adiposity, lipids, and body composition.

The Future of Longevity Medicine Starts Here

The Future of Longevity Medicine Starts Here

What stayed with me across these conversations was just how much the lens of longevity medicine is expanding. We explored exciting new science, emerging technologies, and powerful clinical insights, but we also found ourselves asking deeper questions about what it means to be human, how we want to live, and what truly supports a long and well-lived life. I think you’ll appreciate the breadth of perspectives in this episode—and the reminder that the future of longevity medicine can be both scientifically rigorous and deeply human. ~DrKF

Why Chronic Disease May Begin Before Birth

Why Chronic Disease May Begin Before Birth

As functional medicine clinicians, we often spend our careers helping patients reverse years, sometimes decades, of accumulated dysfunction. But what if some of the most powerful opportunities to influence lifelong health occur long before symptoms ever appear? What if they begin before pregnancy, or even before conception? That’s what makes this conversation so exciting. I sat down with Emily Crouch, Leslie Stone, and Dr. Kalea Wattles to explore the rapidly evolving science connecting preconception health, epigenetics, precision nutrition, and the Developmental Origins of Health and Disease. Together, we discuss why fertility is about so much more than achieving pregnancy. It’s a unique biological window with the potential to influence metabolic health, immune function, neurodevelopment, and chronic disease risk across generations. This conversation also challenged me to think differently about prevention. Functional medicine has always emphasized identifying root causes before disease develops. Preconception care may represent one of the earliest and most impactful opportunities to do exactly that. Whether you work in reproductive health or simply want to better understand where lifelong health truly begins, I think you’ll find this discussion both thought-provoking and clinically inspiring. ~DrKF

The Skin Longevity Breakthrough | Carolina Reis Oliveira

The Skin Longevity Breakthrough | Carolina Reis Oliveira

The skin has long been treated as a cosmetic concern, but emerging science suggests it’s much more than that. As our largest organ, the skin serves as a critical barrier between us and the outside world, yet it also plays an active role in immune function, inflammation, and healthy aging. As skin ages, the accumulation of senescent cells and declining barrier integrity may contribute not only to wrinkles and visible aging, but also to the chronic, low-grade inflammation that underlies many age-related diseases.

How Medicine Got Menopause Wrong | Dr. Kelly Casperson

How Medicine Got Menopause Wrong | Dr. Kelly Casperson

Menopause is one of the most significant biological transitions a woman will experience, yet the way we’ve defined and managed it has changed remarkably little over the last century. For many women, the conversation still revolves around hot flashes and the absence of menstrual cycles rather than the profound endocrine shift occurring beneath the surface. But if we instead think of menopause as the onset of physiologic hypogonadism, the entire clinical conversation changes. In this episode, Kelly Casperson, MD, challenges long-held assumptions about hormone therapy, menopause, and women’s health. Together, we explore why outdated interpretations of the Women’s Health Initiative continue to shape medical practice decades later, how the recent removal of the boxed warning on vaginal estrogen represents a turning point in women’s health, and why testosterone deserves a much larger role in the conversation. Kelly also makes a compelling case for reframing menopause through the lens of healthspan medicine, emphasizing patient autonomy, individualized care, and the importance of treating the underlying physiology rather than simply managing symptoms. I think this conversation will fundamentally change the way many clinicians think about menopause, hormone therapy, and aging. Check out the show notes at www.drkarafitzgerald.com/fxmed-podcast/ for all the relevant links and resources. ~DrKF

What New Science Says About Building Muscle | Brad Currier

What New Science Says About Building Muscle | Brad Currier

Muscle is having a moment—and for good reason. As functional medicine clinicians, we recognize that muscle isn’t just about strength or athletic performance. It’s central to metabolic health, resilience, mobility, healthy aging, and longevity. Yet resistance training can still feel intimidating for many of our patients, and even for some of us. That’s one of the reasons I was so excited to sit down with Brad Currier, PhD. Brad was part of the team behind the first major update to the American College of Sports Medicine resistance training guidelines since 2009, and he has a remarkable ability to translate exercise science into practical, evidence-based strategies that clinicians can use immediately. In partnership with Timeline, we also explore the emerging science of Urolithin A and mitochondrial health, including exciting research on muscle function, recovery, and performance across sedentary adults, older individuals, and elite athletes. This is an approachable, practical conversation that I think will change how many of us think about prescribing—and supporting—movement as medicine. ~DrKF

The Infection Driving Chronic Illness | Dr. Richard Horowitz

The Infection Driving Chronic Illness | Dr. Richard Horowitz

This was a conversation our team had been looking forward to for a while. We came in with a lot of questions, especially around those chronic, persistent cases that don’t respond the way we expect. Dr. Richard Horowitz, one of the most recognized experts in chronic Lyme disease and complex chronic illness worldwide, did not disappoint. He’s spent decades working with exactly these patients. In this episode, we dig into emerging research around persistent infection and neuroinflammation, including findings that roughly half of his Lyme patients tested positive for biomarkers associated with Alzheimer’s, and what that might mean clinically. He also shares how his MSIDS model connects many of the chronic conditions we see in practice to the same underlying drivers, offering a more systems-based way to approach these cases.